Status:
COMPLETED
Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
Lead Sponsor:
Vanderbilt University
Conditions:
Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Eligibility:
All Genders
18-70 years
Brief Summary
This is a repository to store blood and stem cell samples for future research.
Detailed Description
Our Hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of GVHD by determining the qualitative and quantitative changes in T regulatory cells throughout...
Eligibility Criteria
Inclusion
- Patients 18-70 years old undergoing either autologous transplant or allogeneic transplant for various hematologic conditions
Exclusion
- Patients \< 18 or \> 70 years old undergoing either autologous transplant or allogeneic transplant
Key Trial Info
Start Date :
April 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00179075
Start Date
April 1 2003
End Date
April 1 2008
Last Update
December 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232